Constipation, a common symptom in clinical practice, affects up to 20% of the world's population. It has a significant impact on patient's quality of life and healthcare resources. With advancements in medical knowledge and technology, there is a need to revisit our approach to constipation.
Traditionally, constipation is diagnosed based on clinical symptoms and Rome IV criteria. However, this approach often overlooks underlying pathophysiology. Modern techniques such as high-resolution anorectal manometry and transluminal impedance measurement can provide detailed information about the functional status of the colon and rectum, aiding in accurate diagnosis.
Treatment should be tailored to the individual patient's needs. Lifestyle modifications and over-the-counter laxatives are the first-line treatments. However, for patients with refractory symptoms, newer pharmacological agents like linaclotide and plecanatide, which increase intestinal fluid secretion and transit, can be beneficial.
Biofeedback therapy, which uses sensors to make patients aware of physiological functions, has proven effective in treating pelvic floor dyssynergia, a common cause of constipation. This non-invasive therapy can be a game-changer for patients who do not respond to traditional treatments.
For patients with severe, refractory constipation, surgical interventions such as sacral nerve stimulation and subtotal colectomy are being increasingly considered. These procedures, although invasive, can significantly improve symptoms and quality of life in select patients.
In conclusion, the approach to constipation has evolved significantly over the years. Modern diagnostic tools allow for a more precise understanding of the pathophysiology, leading to personalized treatment plans. Innovative therapies and surgical approaches hold promise for patients with refractory symptoms. As healthcare professionals, we must stay abreast of these advancements to provide optimal patient care.
1.
In myelofibrosis, combinations of rufolitinib reduce spleen volume.
2.
Prostate cancer detection with PET CT and PET MRI is comparable.
3.
Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans
4.
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
5.
EHA: European Hematology Association
1.
Tumor Microenvironment Mapping in Cancer Care
2.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
3.
Preventing Treatment-Induced Peripheral Neuropathy in Cancer Care
4.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
5.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Understanding Blood Clotting Disorders
2.
Thromboprophylaxis In Medical Settings
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation